BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 37452943)

  • 21. Craniopharyngioma: a roadmap for scientific translation.
    Gupta S; Bi WL; Giantini Larsen A; Al-Abdulmohsen S; Abedalthagafi M; Dunn IF
    Neurosurg Focus; 2018 Jun; 44(6):E12. PubMed ID: 29852761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Craniopharyngiomas: progress in pathogenesis and therapeutics].
    Hage M; Lombès M; Chanson P
    Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S46-54. PubMed ID: 25617922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Craniopharyngiomas: The Dawn of a New Era with the Elucidation of Driver Genes].
    Fujio S; Hanaya R
    No Shinkei Geka; 2023 Sep; 51(5):917-928. PubMed ID: 37743344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth patterns of craniopharyngiomas: clinical analysis of 226 patients.
    Pan J; Qi S; Liu Y; Lu Y; Peng J; Zhang X; Xu Y; Huang GL; Fan J
    J Neurosurg Pediatr; 2016 Apr; 17(4):418-33. PubMed ID: 26636252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillary craniopharyngioma: a clinicopathological study of 48 cases.
    Crotty TB; Scheithauer BW; Young WF; Davis DH; Shaw EG; Miller GM; Burger PC
    J Neurosurg; 1995 Aug; 83(2):206-14. PubMed ID: 7616262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radiotherapy and radiosurgery in treatment of craniopharyngiomas].
    Savateev AN; Trunin YY; Mazerkina NA
    Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(3):94-106. PubMed ID: 28665393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy.
    Martinez-Gutierrez JC; D'Andrea MR; Cahill DP; Santagata S; Barker FG; Brastianos PK
    Neurosurg Focus; 2016 Dec; 41(6):E2. PubMed ID: 27903124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of pediatric sellar tumors.
    Jane JA
    Pediatr Endocrinol Rev; 2008 Feb; 5 Suppl 2():720-6. PubMed ID: 18317443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PROP1 and CTNNB1 expression in adamantinomatous craniopharyngiomas with or without β-catenin mutations.
    Cani CM; Matushita H; Carvalho LR; Soares IC; Brito LP; Almeida MQ; Mendonça BB
    Clinics (Sao Paulo); 2011; 66(11):1849-54. PubMed ID: 22086512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Craniopharyngioma.
    Müller HL
    Endocr Rev; 2014 Jun; 35(3):513-43. PubMed ID: 24467716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk-adapted treatment and follow-up management in childhood-onset craniopharyngioma.
    Müller HL
    Expert Rev Neurother; 2016 May; 16(5):535-48. PubMed ID: 26982163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mixed craniopharyngioma: long-term results after gamma knife combined with stereotactic brachytherapy].
    Yu X; Zhang JN; Liu R; Wang YM; Sun JZ; Qi SB; DU YN; Wang HW; Zhao HL; Liu ZH
    Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):631-5. PubMed ID: 24256591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Childhood-onset Craniopharyngioma.
    Otte A; Müller HL
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e3820-e3836. PubMed ID: 34086900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the management of craniopharyngioma in children and adults.
    Jensterle M; Jazbinsek S; Bosnjak R; Popovic M; Zaletel LZ; Vesnaver TV; Kotnik BF; Kotnik P
    Radiol Oncol; 2019 Oct; 53(4):388-396. PubMed ID: 31652121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma.
    Müller HL; Merchant TE; Puget S; Martinez-Barbera JP
    Nat Rev Endocrinol; 2017 May; 13(5):299-312. PubMed ID: 28155902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Craniopharyngioma.
    Jane JA; Laws ER
    Pituitary; 2006; 9(4):323-6. PubMed ID: 17080265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.
    Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Suri V; Sarkar C; Jagdevan A; Sharma BS; Sharma MC
    J Neurooncol; 2017 Jul; 133(3):487-495. PubMed ID: 28500561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential evolution of neurosurgical treatment paradigms for craniopharyngioma based on genomic and transcriptomic characteristics.
    Robinson LC; Santagata S; Hankinson TC
    Neurosurg Focus; 2016 Dec; 41(6):E3. PubMed ID: 27903126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Implication of BRAF V600E and CTNNB1 gene mutations in the pathological classification of craniopharyngioma].
    Xu SS; Wang LM; Zhao LH; He ZL; Gong LP; Lu DH; Teng LH
    Zhonghua Bing Li Xue Za Zhi; 2019 Sep; 48(9):682-687. PubMed ID: 31495087
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.